Plastopil in the First Quarter: Sales Grew, but Cash Flow and Food Margins Still Weigh

Plastopil got in the first quarter what it had been waiting for since the November 2025 acquisitions: a larger revenue base, clearer contribution from the industrial segment, and growth in the U.S. market. But the report still does not close the company’s central question, because the sales growth did not reach net profit and did not reach cash. Revenue rose to NIS 111.4 million, but operating profit fell to NIS 1.9 million, net finance expenses rose to NIS 5.1 million, and the company moved to a NIS 3.0 million loss. Operating cash flow was negative NIS 1.1 million, even though an inventory reduction helped the quarter, because customers and other payables absorbed the improvement. This is not a report proving that the expansion failed. It does show that the expansion still has to prove quality: the industrial segment is improving, the U.S. is growing, but the food segment remains at a very low profitability level and short-term credit continues to rise. The next quarters will be decided less by growth itself and more by three points: whether food margins recover, whether the U.S. operation and the acquired activities start adding profit rather than only revenue, and whether cash flow can cover investments, leases and debt without another increase in short-term bank credit.

A Broader Platform, Still a Margin and Working-Capital Business

Plastopil produces flexible plastic films for food packaging and industrial applications. This is an industrial business in which value is not created by sales volume alone. It is created by the ability to preserve the spread between raw materials, labor, logistics and selling prices, while financing inventory and customer credit without short-term debt consuming the operating improvement.

The quarterly report matters because it is the first quarter in which the Plastnir and Forem acquisitions are already part of the current reporting base. In November 2025 the company acquired Plastnir’s activity through a share issuance valued at NIS 20.3 million, and acquired the U.S. company Forem for a cash amount equal to NIS 9.0 million, subject to working-capital and net-financial-debt adjustments. The previous annual analysis left one question open: whether this expansion would add profitability and cash flow, or mainly enlarge the group and require more funding.

The first quarter gives a partial answer. It shows that the group is indeed broader: revenue rose 17.5% year over year, and U.S. sales rose to NIS 19.9 million from NIS 15.2 million. But it is still not proof of earnings quality. The food segment, which was supposed to be the quality layer through advanced products, recyclable packaging and U.S. penetration, generated only NIS 0.5 million of segment profit. The industrial segment looks better, but its margin also remains low relative to the working-capital burden and debt load.

Another change to watch is the reorganization of production sites in Israel. The company plans to consolidate all Israeli production sites into two locations, Kibbutz Hazorea and Sderot, through the purchase of a new printing line, the transfer of a printing line to Sderot and the transfer of a production line to Kibbutz Hazorea. The Nir Eliyahu and Nir Yitzhak sites are expected to be closed gradually by the end of 2026, and the company expects the transfer costs not to be material. That move makes sense for a company that added activities, but it also raises the execution requirement: the savings and efficiency need to show up in the numbers, not only in the organizational plan.

Growth Arrived, Quality Is Still Mixed

The attractive number in the quarter is revenue. Sales rose to NIS 111.4 million, compared with NIS 94.8 million in the corresponding quarter. The company attributes the increase mainly to the Plastnir and Forem acquisitions, so it cannot be read as clean organic growth in the legacy core. The more important question is what happened to profit on that broader revenue base.

Here the report is less convincing. Gross profit rose to NIS 17.6 million, but selling and marketing expenses increased to NIS 10.7 million and G&A expenses rose to NIS 4.6 million. Operating profit fell to NIS 1.9 million from NIS 2.5 million, even though the revenue base was much larger. EBITDA rose slightly to NIS 9.4 million, but part of the gap comes from higher depreciation and amortization, so EBITDA alone does not solve the earnings-quality question.

The segment split shows the tension most clearly:

The industrial segment is doing what the company needed to see after Plastnir: revenue rose 25.6%, and segment profit nearly doubled to NIS 1.3 million. That is still only a 2.1% margin, but the direction improved. The food segment shows the opposite picture: revenue rose to NIS 49.1 million, but segment profit declined to only NIS 0.5 million. The margin fell to 1.1%, even below the weak full-year 2025 level.

That is the quarter’s edge. If one reads only the revenue increase, the expansion appears to be working. If one breaks down profit, the segment that is supposed to carry the business premium, food, has still not recovered. Within food, Toplex rose to NIS 16.2 million and Pack N Cycle remained relatively high at NIS 9.3 million, but Plastobar and Topaz declined versus the corresponding quarter. This is not a collapse. It is a product basket that still does not translate the broader capabilities into a stable margin.

Cash Remains the Bottleneck

The quarterly report reinforces the issue that stayed open at the end of 2025: Plastopil still needs funding for its growth. Operating cash flow was negative NIS 1.1 million, compared with positive NIS 6.3 million in the corresponding quarter. This happened despite a NIS 10.9 million inventory reduction, because customers consumed NIS 13.8 million and payables and other liabilities declined by NIS 4.6 million.

The gap matters especially for an industrial company that holds inventory, extends customer credit and relies on short-term bank credit. Operating working capital did not truly release cash. Customer balances rose to NIS 106.7 million from NIS 93.1 million at the end of 2025, inventory fell to NIS 114.2 million from NIS 125.3 million, and suppliers were nearly unchanged. In other words, the company reduced inventory, but did not turn all of that improvement into cash in the bank.

To understand all-in cash flexibility after actual cash uses, one has to read cash flow after investments, leases and repayments, not only EBITDA:

This is not an immediate liquidity problem, but it is not a comfortable cash picture either. Short-term credit rose to NIS 130.8 million, compared with NIS 122.5 million at the end of 2025 and NIS 104.5 million in the corresponding quarter. Long-term loans rose to NIS 44.9 million after a NIS 5 million new loan and ordinary repayments. Cash at quarter-end was only NIS 7.9 million.

The covenant note calms the immediate horizon, but does not solve the story. As of the end of 2025 the company complied with all covenants: tangible equity of 27.1% versus a 25% minimum, net short-term debt to operating working capital of 66.9% versus an 80% ceiling, and two debt-to-EBITDA ratios that were below zero under the banks’ formula after deducting operating working capital. The next test will be performed only with the 2026 annual statements in March 2027. Until then the quarterly report leaves the market with a simpler test: whether short-term credit starts to decline, or continues to finance the gap between growth and cash.

The Second Quarter Will Decide Whether Expansion Can Fund Itself

The next quarter starts with the U.S. and raw materials. U.S. sales rose to NIS 19.9 million, and the company notes that this market enjoys higher selling prices than Europe and a less fragmented customer structure. That supports the logic of Forem, but still does not prove that U.S. activity is adding margin. Tariff costs on imports into the U.S. amounted to NIS 0.8 million in the quarter, and the company is trying to reduce the hit through price updates and greater use of U.S.-origin raw materials.

Raw-material prices were generally stable until the second half of March 2026, and then changed materially. Any impact, if it occurs, is expected to appear in the second quarter. A two-to-three-month inventory policy for key raw materials gives the company response time, but can also delay the full hit. The second quarter will therefore be mainly a test of timely price pass-through.

The capital structure remains part of the story. The quarterly materials include the auditor’s consent to include the statements in a shelf prospectus intended to be published in May 2026, and the covenant note mentions actions that have not yet crystallized to strengthen the company’s capital structure. There is no announced capital raise, but the language fits a company that understands funding is not a footnote. Dudi Zavida’s appointment as CEO from May 1, 2026 will matter only if site consolidation, acquisition integration and working-capital management start to show up in the numbers.

The first quarter of 2026 does not close the thesis on Plastopil, but it sharpens it. The group is larger and the industrial segment is starting to improve, but the food segment remains weak, finance expenses consume more than operating profit, and cash flow does not cover the company’s real cash uses. The fair counter-thesis is that it is too early to judge, after acquisitions completed only in November 2025 and a new food line that began operating at the end of 2025. For the market read to improve, food margins need to recover, industrial improvement must continue without draining cash, short-term credit needs to stabilize, and the company needs to pass through tariffs and raw materials without damaging demand.